Trials / Active Not Recruiting
Active Not RecruitingNCT05323591
Prospective Observational Study of Filgotinib in Participants With Rheumatoid Arthritis in France
A Prospective, Non-interventional Study in Patients With Moderate to Severe Active Rheumatoid Arthritis in France Receiving Filgotinib for 2 Years
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 155 (actual)
- Sponsor
- Alfasigma S.p.A. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
An observational study to describe the effectiveness, safety, and patient-reported outcomes (PROs) in participants with moderate to severe active rheumatoid arthritis (RA) in France receiving filgotinib in real-world setting.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Filgotinib | Tablets are administered in accordance with the product label |
Timeline
- Start date
- 2022-05-03
- Primary completion
- 2026-07-01
- Completion
- 2026-07-01
- First posted
- 2022-04-12
- Last updated
- 2025-12-10
Locations
17 sites across 1 country: France
Source: ClinicalTrials.gov record NCT05323591. Inclusion in this directory is not an endorsement.